Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Profit After Tax: 2023-2024

Historic Profit After Tax for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to -$88.0 million.

  • CG Oncology's Profit After Tax fell 114.69% to -$43.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$151.5 million, marking a year-over-year decrease of 108.16%. This contributed to the annual value of -$88.0 million for FY2024, which is 81.12% down from last year.
  • Per CG Oncology's latest filing, its Profit After Tax stood at -$88.0 million for FY2024, which was down 81.12% from -$48.6 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Profit After Tax registered a high of -$48.6 million during FY2023, and its lowest value of -$88.0 million during FY2024.
  • For the 2-year period, CG Oncology's Profit After Tax averaged around -$68.3 million, with its median value being -$68.3 million (2023).
  • Data for CG Oncology's Profit After Tax shows a maximum YoY plummeted of 81.12% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Profit After Tax stood at -$48.6 million in 2023, then tumbled by 81.12% to -$88.0 million in 2024.